227 related articles for article (PubMed ID: 16641908)
1. Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer.
Zhu CQ; Cutz JC; Liu N; Lau D; Shepherd FA; Squire JA; Tsao MS
Br J Cancer; 2006 May; 94(10):1452-9. PubMed ID: 16641908
[TBL] [Abstract][Full Text] [Related]
2. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM
Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic significance of telomerase activity and hTERT mRNA expression in non-small cell lung cancer.
Hara H; Yamashita K; Shinada J; Yoshimura H; Kameya T
Lung Cancer; 2001 Nov; 34(2):219-26. PubMed ID: 11679180
[TBL] [Abstract][Full Text] [Related]
4. Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer.
Miura N; Nakamura H; Sato R; Tsukamoto T; Harada T; Takahashi S; Adachi Y; Shomori K; Sano A; Kishimoto Y; Ito H; Hasegawa J; Shiota G
Cancer Sci; 2006 Dec; 97(12):1366-73. PubMed ID: 17052260
[TBL] [Abstract][Full Text] [Related]
5. Clinical and prognostic value of hTERT mRNA expression in patients with non-small-cell lung cancer.
Zalewska-Ziob M; Dobija-Kubica K; Biernacki K; Adamek B; Kasperczyk J; Bruliński K; Ostrowska Z
Acta Biochim Pol; 2017; 64(4):641-646. PubMed ID: 29141053
[TBL] [Abstract][Full Text] [Related]
6. Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer.
Sirera R; Bremnes RM; Cabrera A; Jantus-Lewintre E; Sanmartín E; Blasco A; Del Pozo N; Rosell R; Guijarro R; Galbis J; Sánchez JJ; Camps C
J Thorac Oncol; 2011 Feb; 6(2):286-90. PubMed ID: 21252717
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with nonsmall cell lung carcinoma.
Fujita Y; Fujikane T; Fujiuchi S; Nishigaki Y; Yamazaki Y; Nagase A; Shimizu T; Ohsaki Y; Kikuchi K
Cancer; 2003 Sep; 98(5):1008-13. PubMed ID: 12942569
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of hTERT mRNA expression in surgical samples of lung cancer patients: the European Early Lung Cancer Project.
Van den Berg RM; Brokx H; Vesin A; Field JK; Brambilla C; Meijer CJ; Sutedja GT; Heideman DA; Postmus PE; Smit EF; Snijders PJ
Int J Oncol; 2010 Aug; 37(2):455-61. PubMed ID: 20596673
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of hTERT expression in non-small cell lung cancer.
Komiya T; Kawase I; Nitta T; Yasumitsu T; Kikui M; Fukuoka M; Nakagawa K; Hirashima T
Int J Oncol; 2000 Jun; 16(6):1173-7. PubMed ID: 10811992
[TBL] [Abstract][Full Text] [Related]
10. Detecting cell-free circulating hTERT mRNA in the plasma may identify a subset of nonsmall cell lung cancer patients.
Pelosi G; Schianchi E; Dell'orto P; Veronesi G; Spaggiari L; Pasini F; Sozzi G; Brambilla E; Griso C; Viale G
Virchows Arch; 2006 Jan; 448(1):7-15. PubMed ID: 16193293
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours.
Lantuejoul S; Soria JC; Moro-Sibilot D; Morat L; Veyrenc S; Lorimier P; Brichon PY; Sabatier L; Brambilla C; Brambilla E
Br J Cancer; 2004 Mar; 90(6):1222-9. PubMed ID: 15026805
[TBL] [Abstract][Full Text] [Related]
12. hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer.
Wang L; Soria JC; Kemp BL; Liu DD; Mao L; Khuri FR
Clin Cancer Res; 2002 Sep; 8(9):2883-9. PubMed ID: 12231532
[TBL] [Abstract][Full Text] [Related]
13. [Relationships among expressions of hTERT, MDR1, MRP mRNA, and C-myc protein in non-small cell lung cancer].
Li L; Xiong YY; Liu L; Chen TX; Yao XF; Wang YW
Ai Zheng; 2005 Jan; 24(1):53-7. PubMed ID: 15642200
[TBL] [Abstract][Full Text] [Related]
14. Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma.
Takuma Y; Nouso K; Kobayashi Y; Nakamura S; Tanaka H; Matsumoto E; Fujikawa T; Suzuki M; Hanafusa T; Shiratori Y
J Gastroenterol Hepatol; 2004 Nov; 19(11):1300-4. PubMed ID: 15482538
[TBL] [Abstract][Full Text] [Related]
15. Prediction of survival in stage I lung carcinoma patients by telomerase function evaluation.
Marchetti A; Pellegrini C; Buttitta F; Falleni M; Romagnoli S; Felicioni L; Barassi F; Salvatore S; Chella A; Angeletti CA; Roncalli M; Coggi G; Bosari S
Lab Invest; 2002 Jun; 82(6):729-36. PubMed ID: 12065683
[TBL] [Abstract][Full Text] [Related]
16. hTERT gene amplification and clinical significance in pleural effusions of patients with lung cancer.
Cha N; Li XY; Zhao YJ; Wang EH; Wu GP
Clin Lung Cancer; 2012 Nov; 13(6):494-9. PubMed ID: 22464057
[TBL] [Abstract][Full Text] [Related]
17. Increased telomerase activity and elevated hTERT mRNA expression during multistage carcinogenesis of squamous cell carcinoma of the lung.
Shibuya K; Fujisawa T; Hoshino H; Baba M; Saitoh Y; Iizasa T; Sekine Y; Suzuki M; Hiroshima K; Ohwada H
Cancer; 2001 Aug; 92(4):849-55. PubMed ID: 11550157
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
[TBL] [Abstract][Full Text] [Related]
19. Real-time PCR quantification of human telomerase reverse transcriptase (hTERT) in colorectal cancer.
Saleh S; Lam AK; Ho YH
Pathology; 2008 Jan; 40(1):25-30. PubMed ID: 18038311
[TBL] [Abstract][Full Text] [Related]
20. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
Takihana Y; Tsuchida T; Fukasawa M; Araki I; Tanabe N; Takeda M
Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]